The EU Strategy on COVID-19 Therapeutics identifies five promising candidate therapeutics
The EU Strategy on COVID-19 Therapeutics delivers today its first outcome, with the announcement of the first portfolio of five therapeutics that could soon be available to treat patients across the EU.